MRSA

>

Latest News

Persistent Fever as a Key Mortality Predictor in MRSA Bacteremia
Persistent Fever as a Key Mortality Predictor in MRSA Bacteremia

February 20th 2025

Sean Ong discusses how persistent fever beyond 72 hours emerges as a stronger predictor of mortality in MRSA bacteremia compared to CRP and WBC counts.

Investigational Staphylococcus aureus Vaccine Begins Phase 1 Study
Investigational Staphylococcus aureus Vaccine Begins Phase 1 Study

February 18th 2025

Shifting Patterns of Staphylococcus aureus Infections in Pediatric Patients
Shifting Patterns of Staphylococcus aureus Infections in Pediatric Patients

October 2nd 2024

Similar Efficacy of Ceftaroline and Vancomycin in Treating Complicated Skin and Soft Tissue Infections
Similar Efficacy of Ceftaroline and Vancomycin in Treating Complicated Skin and Soft Tissue Infections

May 11th 2024

Exebacase Combined With Antibiotics Fails to Improve MRSA Bacteremia Outcomes
Exebacase Combined With Antibiotics Fails to Improve MRSA Bacteremia Outcomes

February 8th 2024

Video Series
Video Interviews

More News

© 2025 MJH Life Sciences

All rights reserved.